Milos Mladenovic
0000-0002-8350-2182
3 papers found
Refreshing results…
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Missing publications? Search for publications with a matching author name.